Cirrhosis News and Research

Latest Cirrhosis News and Research

Australia has potential to eradicate hepatitis C in 10–15 years, says expert

Australia has the potential to eradicate hepatitis C in the next 10–15 years, according to Associate Professor Simone Strasser, gastroenterologist at Royal Prince Alfred Hospital in Sydney.

4 Apr 2017

Study shows how early-life BPA exposure leads to NAFLD in adulthood

Exposure during infancy to the common plasticizer bisphenol A "hijacks" and reprograms genes in the liver of newborn rats, leading to nonalcoholic fatty liver disease in adulthood.

2 Apr 2017

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

All causes of the most common form of liver cancer, hepatocellular carcinoma, are not yet known, but the risk of getting it is increased by hepatitis B or C, cirrhosis, obesity, diabetes, a buildup of iron in the liver, or a family of toxins called aflatoxins produced by fungi on some types of food.

29 Mar 2017

Loss of partner to suicide may increase risk for mental and physical disorders

People who lose a partner to suicide are at increased risk for a number of mental and physical disorders, including cancer, depression, herniated discs and mood disorders than those in the general population, new Johns Hopkins Bloomberg School of Public Health research suggests.

22 Mar 2017

Study underscores need to increase awareness for HCV testing among baby boomers

A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force recommended it for all baby boomers, and finds rates are still very low.

8 Mar 2017

Dietary fructose consumption may increase risk for NASH in children and adolescents

Recent research suggests that dietary fructose intake may increase serum uric acid concentrations and that both uric acid concentration and fructose consumption may be increased in individuals with non-alcoholic fatty liver disease.

14 Feb 2017

New analysis reveals low incidence of liver cancer in patients with cirrhosis

Although one of the most serious complications of cirrhosis is liver cancer, or hepatocellular carcinoma (HCC), an analysis of health records revealed that the 10-year incidence of HCC in UK patients with cirrhosis is four percent or lower.

1 Feb 2017

Scientists shed new light on how common painkiller causes liver damage

Scientists have shed new light on how the common painkiller paracetamol causes liver damage.

31 Jan 2017

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

24 Jan 2017

Scientists generate new index to accurately predict presence of fatty liver disease

Non-alcoholic fatty liver disease has become a global epidemic. There is not only a great interest worldwide to understand the causes and consequences of fatty liver disease, but also to diagnose fatty liver disease at an early stage.

23 Jan 2017

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient’s response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is significant because it may help physicians tailor more effective treatments for the up to 2.2 million individuals infected with HBV.

23 Jan 2017

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

Use of an advanced form of the commonly used polymerase chain reaction (PCR) method to analyze circulating tumor cells (CTCs) may greatly increase the ability to diagnose early-stage cancer, increasing the likelihood of successful treatment.

20 Jan 2017

Researchers uncover new pathway in the body that stimulates liver repair

A team of Michigan State University researchers, led by James Luyendyk in the College of Veterinary Medicine, has uncovered a new pathway in the body that stimulates liver repair.

19 Jan 2017

Study provides insights into CPEB4 gene and fatty liver disease

This condition generally leads to chronic inflammation (non-alcoholic steatohepatitis), which can trigger fibrosis, cirrhosis and ultimately liver cancer. This study on the basic biology of the liver paves the way to examine therapeutic strategies to fight and prevent fatty liver disease.

18 Jan 2017

Epigenetic changes favor development of fatty liver in humans and mice

Mice with a strong tendency to obesity already exhibit epigenetic changes at six weeks of age, inducing the liver to amplify its production of the enzyme DPP4 and release it into the circulation. Over the long term, this favors the development of a fatty liver.

9 Jan 2017

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease, a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure, and likely other liver diseases.

9 Dec 2016

Newcastle scientists develop promising new test to identify patients with rare liver disease

Newcastle scientists and medics have developed a promising new test to identify patients with a rare liver disease who will not respond to standard treatment, allowing earlier intervention with alternatives.

2 Dec 2016

Over-the-counter and prescription pain medications linked to drug-induced liver injury

More than 1,000 medications, with acetaminophen being the most common, have been associated with drug-induced liver injury.

30 Nov 2016

Research provides insight into molecular mechanisms involved in immune response to HBV

The innate immune system in mammals defends against infection from viruses and other microbial infections.

28 Nov 2016

Women more susceptible to damaging effects of alcohol, says Houston Methodist expert

"One drink a day might be too much for a woman who has a genetic pre-disposition to cirrhosis of the liver," said Howard Monsour, M.D., chief of hepatology at Houston Methodist Hospital "One drink for a woman has about twice the effect as it does for the same amount consumed by a man."

22 Nov 2016

Cirrhosis News and Research

Latest Cirrhosis News and Research

Australia has potential to eradicate hepatitis C in 10–15 years, says expert

Study shows how early-life BPA exposure leads to NAFLD in adulthood

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

Loss of partner to suicide may increase risk for mental and physical disorders

Study underscores need to increase awareness for HCV testing among baby boomers

Dietary fructose consumption may increase risk for NASH in children and adolescents

New analysis reveals low incidence of liver cancer in patients with cirrhosis

Scientists shed new light on how common painkiller causes liver damage

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

Scientists generate new index to accurately predict presence of fatty liver disease

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

Researchers uncover new pathway in the body that stimulates liver repair

Study provides insights into CPEB4 gene and fatty liver disease

Epigenetic changes favor development of fatty liver in humans and mice

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

Newcastle scientists develop promising new test to identify patients with rare liver disease

Over-the-counter and prescription pain medications linked to drug-induced liver injury

Research provides insight into molecular mechanisms involved in immune response to HBV

Women more susceptible to damaging effects of alcohol, says Houston Methodist expert

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cirrhosis News and Research

Latest Cirrhosis News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in